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Granular corneal dystrophy type II (GCD II) is an
autosomal dominant disorder characterized by age-
dependent progressive accumulation of transforming
growth factor--induced protein (TGFBIp) deposits in
the corneal stroma. Several studies have suggested
that corneal fibroblasts may decline with age in re-
sponse to oxidative stress. To investigate whether ox-
idative stress is involved in the pathogenesis of GCD
II, we assayed antioxidant enzymes, oxidative dam-
age, and susceptibility to reactive oxygen species-in-
duced cell death in primary cultured corneal fibro-
blasts (PCFs) from GCD II patients and healthy
subjects. We found elevated protein levels of Mn-su-
peroxide dismutase, Cu/Zn-superoxide dismutase,
glutathione peroxidase, and glutathione reductase, as
well as increased CAT mRNA and decreased catalase
protein in GCD II PCFs. Furthermore, catalase is
down-regulated in normal PCFs transfected with
transforming growth factor--induced gene-h3. We
also observed an increase in not only intracellular
reactive oxygen species and H2O2 levels, but also mal-
ondialdehyde, 4-hydroxynonenal, and protein carbon-
yls levels in GCD II PCFs. Greater immunoreactivity for
malondialdehyde was observed in the corneal tissue of
GCD II patients. In addition, we observed a decrease in
Bcl-2 and Bcl-xL levels and an increase in Bax and Bok
levels in GCD II PCFs. Finally, GCD II PCFs are more
susceptible to H2O2-induced cell death. Together ,
these results suggest that oxidative damage induced
by decreased catalase is involved in GCD II pathogene-
sis, and antioxidant agents represent a possible treat-
ment strategy. (Am J Pathol 2009, 175:248–261; DOI:
10.2353/ajpath.2009.081001)
The cornea, made up of avascular tissue that maintains
transparency at the frontal surface of the eye,1 contains
three major layers: the outer epithelium, a thick stroma
with corneal fibroblasts, and the inner endothelium. Cor-
neal tissue is chronically exposed to environmental oxi-
dative stimuli such as solar UV radiation and high levels
of oxygen,2 and is known to be particularly susceptible to
oxidative stress.3 For example, the number of corneal
fibroblasts declines in normal corneas with age in re-
sponse to oxidative stress.4,5
Reactive oxygen species (ROS) form as products under
normal physiological conditions due to the partial reduction
of molecular oxygen in mitochondria.5,6 Eukaryotic cells
also have several antioxidative defense mechanisms, in-
cluding enzymes and antioxidants.6 There are five major
types of primary intracellular antioxidant enzymes: Cu/Zn-
superoxide dismutase (SOD), Mn-SOD, catalase, glutathi-
one peroxidase (GPx), and glutathione reductase (GR). The
SODs convert O2
 into H2O2, while catalase and GPx con-
vert H2O2 into H2O.
6 Reactive oxygen species (ROS) can
be generated at elevated rates under normal aging and
pathophysiological conditions.5,6 Oxidative stress occurs
due to excessive ROS production, an impaired antioxidant
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system, or a combination of these factors.5,7–9 Excessive
ROS can cause oxidative damage to proteins, lipids, and
DNA. There are several markers of oxidative damage, in-
cluding 8-hydroxy-2-deoxyguanosine (8-OHdG, a marker
of oxidative damage to DNA), malondialdehyde (MDA, a
marker of lipid peroxidation), 4-hydroxynonenal (4-HNE, a
marker of lipid peroxidation), and protein carbonyl groups
(a marker of protein oxidation). Cell death induced by oxi-
dative stress is involved in the pathologies of various dis-
eases1,10 including cataract,11 glaucoma,12,13 Alzheimer’s
disease,14,15 Parkinson’s disease,16,17 and prion dis-
ease.18,19 Furthermore, oxidative cell stress is a common
phenomenon in protein misfolding diseases.20,21 Aggre-
gated forms of many amyloidogenic proteins are toxic to
cells via oxidative stress, linking protein aggregation and
pathological damage to the tissues in which they are
found.20,21
Granular corneal dystrophy type II (GCD II) is autosomal
dominant disorder caused by point mutations (R124H) in
transforming growth factor--induced gene-h3 (BIGH3).
Age-dependent progressive accumulation of hyaline and
amyloid are hallmarks of GCD II, which is characterized by
the production of transforming growth factor--induced pro-
tein (TGFBIp) encoded by BIGH3 in the corneal epithelia
and stroma, interfering with corneal transparency.22–24 TG-
FBIp is an extracellular matrix protein that is incorporated
into deposits in the three major forms of dominant corneal
dystrophy caused by different mutation loci in the BIGH3
gene: the granular type (types I and II; type II is also called
Avellino corneal dystrophy), the lattice type (lattice corneal
dystrophy types I, III, and IV), and the type with diffuse
deposits in Bowman’s layer (Reis Buehler corneal dystro-
phies and Thiel Behnke corneal dystrophy).23 However, it
has not been investigated so far in the context of the world-
wide frequency of these disorders. Recently, it has only
been reported that 22 homozygous GCD II patients have
been found in South Korea.25 From these results, the fre-
quency of GCD II has been estimated to be 1/1400 in the
population of South Korea (manuscript in submission).
Recently, we reported that mitomycin C induces more
apoptosis in primary cultured corneal fibroblasts (PCFs)
from GCD II patients than wild-type PCFs via reduced
Bcl-xL and increased Bax gene expression.26 Mitomycin C
induces ROS generation through redox cycling.27,28 Taken
together, these data suggest that GCD II PCFs are highly
susceptible to ROS-induced cell death, as compared with
wild-type PCFs. Therefore, in the present study, we investi-
gated the involvement of oxidative stress in corneal fibro-
blast degeneration in GCD II by measuring the extent of
oxidative damage and the status of the antioxidant enzyme
defensive system of PCFs from heterozygous or homozy-
gous GCD II patients and wild-type subjects.
Materials and Methods
Isolation and Culture of PCFs
PCFs were prepared from healthy corneas from the eye
bank and from heterozygote or homozygote GCD II pa-
tients after penetrating or lamellar keratoplasty. Donor
confidentiality was maintained according to the Declara-
tion of Helsinki and was approved by Severance Hospital
IRB Committee (CR04124), Yonsei University. GCD II was
diagnosed by DNA sequencing analysis of BIGH3 gene
mutations. Age, gender, and diagnosis for all GCD II
cases used in this study are listed in Table 1. Corneas
were washed three times with Dulbecco’s modified Ea-
gle’s medium (DMEM; Gibco BRL, Grand Island, NY)
containing 1000 units/ml penicillin and 1.0 mg/ml strep-
tomycin sulfate (Gibco BRL, Grand Island, NY). The cor-
neal epithelium was then removed by scraping the epi-
thelial surface and detaching Descemet’s membrane
with a fine forceps and blade. Corneal tissues were
placed on 30-mm culture dishes and DMEM containing
1000 units/ml penicillin, 1.0 mg/ml streptomycin sulfate,
and 10% fetal bovine serum (Invitrogen-Life Technolo-
gies) was added gently. After 48 hours, migratory fibro-
blasts from the corneal button could be found. These
PCFs were maintained in DMEM with 10% fetal bovine
serum at 37°C under 95% humidity and 5% CO2. The
medium was changed every 3 days. When the cultured
corneal fibroblasts were 80% to 90% confluent, the
cells were subcultured with 0.25% trypsin and 5.0 mmol/L
EDTA at a 1:3 split. Cells from passages 5 to 8 were used
in the experiments. The normal human corneal fibroblast
cell line29 was kindly provided by Dr. James Jester and
were cultured in DMEM with 10% fetal bovine serum at
37°C in a humidified incubator with 95% air and 5% CO2.
Preparation of Small Interfering RNA and
Transfection
RNA interference (RNAi) oligoribonucleotides corre-
sponding to the following cDNA sequences were pur-
chased from Santa Cruz (Santa Cruz Biotechnology,
Santa Cruz, CA): 5-CCACTAGTCTGACTGATGA-3 for
the human CAT gene. Cells were cultured in DMEM at
37°C in 5% CO2 atmosphere. The 0.5-nmol small inter-
fering RNA (siRNA) were transfected by lipofectamine
2000 (Invitrogen). The media were supplemented with
10% fetal bovine serum (Invitrogen Life Technologies),
Table 1. Cases Used for Analysis in This Study
Case no.
Pathological
diagnosis Sex Age Mean age
1 CON-WT F 20
2 CON-WT M 10 26.25
3 CON-WT M 29
4 CON-WT M 46
5 GCD II-HE F 37
6 GCD II-HE F 20 32.50
7 GCD II-HE M 24
8 GCD II-HE M 49
9 GCD II-HO F 27
10 GCD II-HO M 10
11 GCD II-HO F 13 20.2
12 GCD II-HO F 29
13 GCD II-HO M 22
CON-WT, control case; GCD II-HE, heterozygote of granular corneal
dystrophy type II case; GCD II-HO, homozygote of granular corneal
dystrophy type II case; F, female; M, male.
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penicillin (100 U/ml), and streptomycin sulfate (100 g/
ml; Invitrogen Life Technologies). Cells were then cul-
tured in growth medium for 48 hours before further
analysis.
RNA Isolation and Reverse Transcription-PCR
For amplification of BIGH3, CAT, and -actin, total RNA
was isolated from control wild-type, heterozygous, and
homozygous PCFs by extraction in TRIZOL Reagent (In-
vitrogen Life Technologies, Carlsbad, CA). cDNA synthe-
sis and DNA amplification was performed by using the
SuperscriptTM One-Step reverse transcription (RT)-PCR
System (Invitrogen Life Technologies, Carlsbad, CA) and
primers specific for BIGH3 (forward primer, 5-GTGTGT-
GCTGTGCAGAAGGT-3; reverse primer, 5-TTGAGAGT-
GGTAGGGCTGCT-3), CAT (forward primer, 5-ATC-
TCGTTGGAAATAACACC-3; reverse primer, 5-AGA-
AACCTGATGCAGAGACT-3), and -actin (forward primer,
5-GGACTTCGAGCAAGAGATGG-3; reverse primer, 5-AG-
CACTGTGTTGGCGTACAG-3), respectively.
BIGH3 cDNA Cloning
Wild-type and mutant BIGH3 cDNAs were obtained by
RT-PCR from total RNA isolated from wild-type or homozy-
gous PCFs by using forward (5-CACCATGGCGCTCT-
TCGTGC-3) and reverse (5-CTAATGCTTCATCCTCTCTA-
3) oligonucleotides. These cDNAs were subcloned into
pcDNA 3.1 vector (Invitrogen Life Technologies, Carlsbad,
CA). The resulting plasmids were sequenced in both direc-
tions to check the orientation of the insert.
Cell Viability
PCFs were plated in 96-well plates at 10,000 cells/well
overnight. Cell proliferation was determined using the
CellTiter 96 AQueous One Solution Reagent Cell Prolifer-
ation Assay Kit using the tetrazolium compound (3-[4,5-
dimethylthiazol-2-yl]-5-(3-carboxymethoxyphenyl)-2-[4-sulf-
ophenyl]-2H- tetrazolium, inner salt; MTS) (Cat. No. G3580;
Promega, Madison, WI). Briefly, the culture medium was
removed and then 20 l of MTS solution was added to each
well in 100 l of culture medium. The cultures were incu-
bated at 37°C for 2 to 4 hours under 95% humidity and 5%
CO2. Optical density was measured with a plate reader with
a filter setting at 450 nm (reference filter setting, 690 nm).
Fluorescence-Activated Cell Sorting Analysis
Annexin V fluorescence-activated cell sorting (FACS)
analysis was performed according to the manufacturer’s
protocol (Annexin V Fluorescent in situ apoptosis detec-
tion kit, BioBud Company, Seoul, Korea). Approximately
1 104 cells/well were plated into 100 mm2 tissue culture
dishes (Becton Dickinson, NJ). On day 0, the medium
was replaced with fresh medium. On day 2, the medium
was replaced with medium containing 100 or 200 mol/L
H2O2 and harvested after 6 hours. Cells were accutase-
treated and washed with PBS pH 7.4 (Cat. No. 10010;
Invitrogen Life Technologies, Carlsbad, CA), and 1 106
cells were resuspended in 100 l annexin V incubation
buffer and incubated for 15 minutes at room temperature
in the dark. A total of 400 l of 1 binding buffer was
added to each sample and the samples were analyzed
on a FACS Calibur flow cytometer (Becton-Dickinson Im-
munocytometry Systems, San Jose, CA).
Preparation of Cell Lysates and Western Blot
Analysis
Cell lysates from PCFs were prepared in radio-immuno-
precipitation assay buffer (RIPA buffer; 150 mmol/L NaCl,
1% NP-40, 0.5% deoxycholate, 0.1% SDS, 50 mmol/L
Tris-HCl, pH 7.4) containing a protease inhibitor tablet
(Complete Mini Protease Inhibitor Tablet, Roche #
1836170). Crude cell lysates were centrifuged at 10,000 
g for 10 minutes at 4°C to remove nuclear fragments and
tissue debris. A portion of the supernatant was used to
determine the total protein concentration with a bicincho-
ninic acid kit (Pierce). Total cellular proteins were elec-
trophoresed in 10% Tris-glycine SDS polyacrylamide
gels. Proteins were transferred onto polyvinylidene di-
fluoride membranes (Millipore Corp., Bedford, MA),
blocked in 5% dry milk in TBS-T (0.02 mol/L Tris/0.15
mol/L NaCl, pH 7.5 containing 0.1% Tween 20) at room
temperature for 1 hour, washed three times with TBS-T
and then incubated with primary antibodies to TGFBIp
(0.2 g/ml; Cat. No. AF2935; R&D System), Cu/Zn-SOD
(1:1000 dilution; Cat. No. SOD100; Stressgen, Victoria
BC, Canada), Mn-SOD (1:1000 dilution; Cat. No.
SOD110; Stressgen, Victoria BC, Canada), catalase (1:
500 dilution; Cat. No. ab1877, Abcam, Cambridge, UK),
GPx (1:250 dilution; Cat. No. LF-PA0087; AbFrontier,
Seoul, Korea), GR (1:5000 dilution; Cat. No. LF-PA0087;
AbFrontier, Seoul, Korea), -actin (1:5000 dilution; Cat.
No. A-5441; Sigma Chemical Co., St. Louis, MO), or LC3
(1:1000 dilution; Cell Signaling Technology, Beverly, MA)
for overnight at 4°C. Pro-survival (Cat. No. #9941) and
pro-apoptosis (Cat. No. #9942) Bcl-2 family antibody
sampler kits (Cell Signaling Technology Inc., Beverly,
MA) were used to analyze apoptosis-related proteins.
After washing three times with TBS-T, the blots were
incubated with secondary antibodies conjugated with
horseradish peroxidase at room temperature for 1 hour.
Horseradish peroxidase-linked anti-mouse IgG (1:5000
dilution; Cat. No. NA931V) or anti-rabbit IgG (1:5000
dilution; Cat. No. NA934V) was used as a secondary
antibody (Amersham Pharmacia Biotech., Piscataway,
NJ). Immunoblots were visualized using the enhanced
chemiluminescence system (Pierce; Rockford, IL). The
intensities of immunoreactive protein bands were image-
scanned and optical densities of the bands were quan-
tified using computer software (ImageJ software, version
1.37, Wayne Rasband, NIH), corrected by background
subtraction and normalized to the intensity of the corre-
sponding -actin protein bands.
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Antioxidant Enzyme Activity Assay
Cells were homogenized in ice-cold KCl buffer (0.3 M/L
KCl, 0.15 M/L K2HPO4, 10 mmol/L Na4P2O7, 1 mmol/L
MgCl2 [pH 6.8]) and centrifuged at 10,000  g for 10
minutes at 4°C. Protein concentrations of the superna-
tants were measured by the bicinchoninic acid protein
assay (Pierce BCA-200 Protein Assay kit; Rockford, IL).
SOD activity was determined with the SOD Assay Kit-
WST (Dojindo Inc., Kumamoto, Japan) in PCFs from the
rate of reduction of cytochrome c, with 1U of SOD activity
defined as the amount of SOD required to inhibit the rate
of cytochrome c reduction by 50%. SOD activity was
expressed as U/mg protein. Catalase activity was as-
sayed by monitoring the loss of absorbency of H2O2 at
240 nm; 1U was the amount of enzyme that decomposed
1 mmol/L H2O2/min.
30
Measurement of Intracellular ROS and H2O2
Generation
Dichlorofluorescein diacetate (DCF-DA; Sigma Chemical
Co., St. Louis, MO) was dissolved in ethanol to a final
concentration of 20 mmol/L before use. Cells were
washed twice with PBS to remove endogenous esterase
activity in the FBS. To measure ROS, cells were incu-
bated with 10 mmol/L DCF-DA at 37°C for 30 minutes.
Extracellular DCF-DA was removed by washing twice
with PBS. The fluorescence intensity was recorded using
a fluorescent microplate reader (HTS 7000, Perkin-Elmer
Corp., Norwalk, CT) with an excitation filter of 485 nm and
an emission filter of 535 nm. To measure intracellular
H2O2, cells were washed twice with PBS and then incu-
bated with 5 mmol/L BES-H2O2 (Wako Pure Chemical
Co., Osaka, Japan) at 37°C for 60 minutes. Extracellular
BES-H2O2 was removed by washing twice with PBS. The
fluorescence intensity was recorded using a lumines-
cence spectrometer (LS50B, Perkin-Elmer Corp., Nor-
walk, CT) with an excitation filter of 485 nm and an emis-
sion filter of 515 nm. Data were calculated as the
percentage of fluorescence intensity of wild-type control
cultures.
Analysis of MDA, 4-HNE, and Protein Carbonyl
Group Levels
The level of protein carbonyl groups as markers of oxi-
dized protein in GCD II PCFs patients was determined
using an OxyBlot protein oxidation detection kit (Cat. No.
S7150; Chemicon, Temecula, CA) according to the man-
ufacturer’s protocol. Briefly, whole cell extracts were an-
alyzed for protein oxidation by derivatization of protein
carbonyls with 2, 4-dinitrophenyl hydrazine by Western
blotting using anti-2,4-dinitrophenyl hydrazine antibody
(1:150 dilutions). After determining the protein content of
each fraction, equal amounts of protein were separated
by 10% Tris-Tricin SDS-polyacrylamide gel electrophore-
sis, followed by Western blot transfer to polyvinylidene
difluoride membranes (Millipore Corp., Bedford, MA),
and visualized by chemiluminescence. Proteins that un-
derwent carbonyl group formation were assayed as a
band in the samples derivatized with 2,4-dinitrophenyl
hydrazine. The same samples were processed for detec-
tion of 4-HNE and MDA adducts by immunoblotting using
anti-4-HNE (1:500 dilution; Cat. No. 4-HNE11-S; Alpha
Diagnostic, San Antonio, TX) and anti-MDA (1:500 dilu-
tion; Cat. No. MDA11-S;  Diagnostic, San Antonio, TX)
polyclonal antibodies developed against 4-HNE- and
MDA-adducted proteins (Alpha Diagnostic, San Antonio,
TX). Blots were analyzed using ImageJ analysis software
(version 1.37, Wayne Rasband, NIH).
Immunocytochemical Staining
Wild-type, heterozygous, and homozygous PCFs grown
on culture slides (Cat. No. REF 354108; BD Falcon, La-
bware, Franklin Lakes, NJ) were permeabilized and fixed
in methanol at 20°C for 3 minutes. Cells were washed in
PBS, blocked with 10% bovine serum albumin (Sigma) in
PBS for 10 minutes, and incubated with primary antibody
in blocking buffer for 1 hour at 37°C. Cells were incu-
bated with secondary antibodies for 1 hour at 37°C. The
coverslips were mounted on glass slides with Vectashield
mounting medium (Vector Labs Inc., Burlingame, CA).
Cells were viewed under a Leica TCS SP5 confocal mi-
croscope (Leica). The following primary antibodies were
used: monoclonal anti-TGFBIp (1:300 dilution; kindly pro-
vided by Dr. IS, Kim, Kyungpook National University,
Korea), polyclonal anti-catalase (1:500 dilution; Cat. No.
ab1877, Abcam, Cambridge, UK), and anti-LAMP2
mouse monoclonal antibody, H4B4 (purchased from De-
velopmental Studies Hybridoma Bank at the University of
lowa). The following secondary antibodies were used: an
Alexa 594 (red)-conjugated anti-rabbit IgG (1:200 dilu-
tion; Vector Laboratories) and fluorescein isothiocyanate
(green)-labeled anti-mouse IgG (1:200 dilution; Jackson
ImmunoResearch Laboratories, West Grove, PA).
Immunohistochemical Staining
Immunohistochemical procedures were performed using
the ABC kit (Vector Labs Inc., Burlingame, CA) with a
modification of the avidin-biotin-peroxidase method.
Briefly, 6-m sections of cornea were dewaxed with xy-
lene and hydrated with graded ethanol, and then treated
with 0.3% H2O2 in methyl alcohol for 20 minutes to block
endogenous peroxidase. After washing three times with
PBS, the sections were exposed to normal goat serum,
and then incubated overnight at 4°C with anti-TGFBIp
(KE-2, 1:50 dilution, kindly provided by Dr. Daniel F.
Schorderet, University of Lausanne, Switzerland) and an-
ti-MDA polyclonal antibodies ( Diagnostic, San Antonio,
TX, Cat. No. MDA11-S, 1:500 dilution). After washing
three times with PBS, the sections were sequentially
treated with biotinylated anti-rabbit/mouse immunoglob-
ulin and avidin-biotin peroxidase complex, and devel-
oped with diaminobenzidine-hydrogen peroxidase solu-
tion (0.003% 3,3-diaminobenzidine and 0.03% hydrogen
peroxidase in 0.05 M/L Tris buffer).
Oxidative Stress in GCD II 251
AJP July 2009, Vol. 175, No. 1
Statistical Analysis
The results were statistically evaluated for significance
(P  0.05) with one-way analysis of variance followed by
Newman-Keuls multiple comparison tests. Results are
expressed as mean SD. All data were processed using
the Graph Pad Prism version 4.0 (Graph Pad Software
Inc, San Diego, CA) statistical package.
Results
Expression of TGFBIp and BIGH3 Gene in
Wild-Type and GCD II PCFs
We have investigated the expression level of TGFBIp in
wild-type, heterozygous, and homozygous PCFs. As
shown in Figure 1, no significant differences in expres-
sion levels of TGFBIp and BIGH3 mRNA were detected
between wild-type, heterozygous, and homozygous
PCFs by Western blot (Figure 1, A and B) and RT-PCR
(Figure 1, C and D), respectively. The molecular weight of
the mutant TGFBIp was similar to that of the wild-type
TGFBIp (70 kDa) (Figure 1A).
Increased Expression of Antioxidant Enzymes in
GCD II PCFs
To find out whether oxidative stress is involved in the de-
generation of GCD II PCFs, we investigated the expression
levels of antioxidant enzymes in heterozygous, homozy-
gous, and wild-type PCFs. As shown in Figure 2, the ex-
pression of both Cu/Zn-SOD and Mn-SOD was significantly
higher in heterozygous and homozygous PCFs (Figure 2,
A–C). Moreover, PCFs homozygous for the mutation dis-
played a greater elevation of Mn-SOD expression than het-
erozygous PCFs (Figure 2, A and C). To determine whether
the protein level of SOD corresponded to the activity level of
enzymes directly involved in ROS scavenging, we mea-
sured the total SODs activity from PCF homogenates. Total
SOD activity was significantly higher in GCD II PCFs, as
compared with wild-type PCFs (Table 2). In addition, to
investigate other antioxidant defensive enzymes, we ana-
lyzed glutathione-related enzymes byWestern blot analysis.
GPx (Figure 2, A and D) and GR (Figure 2, A and E) protein
expression was markedly higher in heterozygous and ho-
mozygous PCFs. Taken together, these results indicate that
GCD II PCFs are under oxidative stress.
GCD II PCFs Exhibit Increased CAT mRNA
Expression Levels but Decreased Catalase
Protein Levels
We found that the level of CAT mRNA was significantly
higher in GCD II PCFs than wild-type PCFs (Figure 3, C and
D). Interestingly, the expression level of catalase protein in
both heterozygous and homozygous PCFs was dramati-
cally lower than in wild-type PCFs (Figure 3, A and B). To
determine whether the catalase protein level corresponded
to the activity level of enzymes directly involved in ROS
scavenging, we measured catalase activities in PCF ho-
mogenates. Catalase activity was significantly lower in GCD
II PCFs than wild-type PCFs (Table 2). In addition, to confirm
the lower catalase protein level in GCD II PCFs, we ana-
lyzed the distribution of catalase protein by confocal immu-
nostaining. Weak immunoreactivity of catalase was ob-
served in GCD II PCFs (Figure 3, E–J).
Intracellular Generation of ROS and H2O2
Increased More in GCD II PCFs than Wild-Type
PCFs
To test whether intracellular ROS are elevated in GCD II
PCFs under differential expression of antioxidant en-
Figure 1. BIGH3 gene and TGFBIp expression
in GCD II PCFs. A: Immunoblot analysis of TG-
FBIp expression among three wild-type (Table
1, samples 1–3), three heterozygous (Table 1,
samples 5–7), and three homozygous (Table 1,
samples 9–11) PCFs, using anti-TGFBIp poly-
clonal goat antibodies. Numbers on the right
correspond to the molecular weight markers in
kilodaltons (kDa). B: Quantification of TGFBIp
in wild-type, heterozygote, and homozygote
PCFs. Western blot shows no significant varia-
tions among wild-type, heterozygote, and ho-
mozygote PCFs. C: RT-PCR analysis of BIGH3
gene expression among two wild-type, three
heterozygote, and three homozygote PCFs, us-
ing human BIGH3 gene specific primers. D:
Quantification of BIGH3 mRNA in wild-type,
heterozygote, and homozygote PCFs. All signals
were quantified by using a NIH image J. Hetero-
zygote (HE) or Homozygote (HO) versus con-
trol wild-type (WT) cultures.
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zymes, intracellular ROS levels were measured by 2,7-
dichlorodihydrofluorescein (DCFH2-DA) following the ox-
idation of DCFH2-DA to fluorescent dichlorofluorescein
(DCF), which detects the generation of intracellular ROS.
As shown in Figure 4A, significantly higher ROS levels
were detected in both heterozygous (2.3-fold) and ho-
mozygous (8.6-fold) PCFs, as compared with wild-type
PCFs. To assess the elevation of H2O2 accurately, we
also used BES-H2O2, a probe for cell-derived H2O2
based on a nonoxidative fluorescence mechanism with
high selectivity to H2O2. The intracellular H2O2 level was
elevated significantly in both heterozygous (3.7-fold) and
homozygous (4.0-fold) PCFs, as compared with wild-type
PCFs (Figure 4B). There were no significant differences
between heterozygous and homozygous PCFs.
Altered Antioxidant Enzyme Expression and
Accumulation of H2O2 by siRNA-Mediated
Suppression of CAT Gene
The decreased catalase prompted us to further investigate
its potential role in this catalase in oxidative stress in GCD II
PCFs. We used the siRNA technique to specifically sup-
press expression of catalase in normal corneal fibroblast
cell lines29 and then examined possible alterations in cellu-
lar ROS content and antioxidant enzyme expression. CAT
siRNA specifically suppressed expression of catalase and
did not affect the expression of -actin (see supplemental
Figure S1 at http://ajp.amjpathol.org). Next, because GPx
also detoxifies H2O2 by catalyzing its decomposition to O2
and H2O, we analyzed expression levels of GPx after sup-
pression of catalase gene expression by siRNA. Expression
levels of GPx are markedly induced in corneal fibroblast cell
lines transfected with CAT siRNA, whereas the control
siRNA did not cause any significant changes in -actin level
(see supplemental Figure S1 at http://ajp.amjpathol.org).
These data suggest that suppression of catalase expres-
sion was sufficient to cause an accumulation of H2O2 in
PCFs, and may support that catalase is a key factor in
oxidative damage in GCD II PCFs. Compared with non-
transfected GCD II PCFs, negative control of CAT siRNA
transfected had slightly reduced catalase expression and
induced ROS, which may reflect the side effects of control
siRNA transfection.
Oxidative Damage in PCFs and Corneal Tissues
of GCD II Patients
Both altered expression of antioxidant enzymes and in-
creased ROS and H2O2 levels are expected to lead to
Figure 2. Antioxidative enzymes are elevated in GCD II PCFs. Immunoblot analysis of antioxidant enzymes expression among three wild-type (WT) (Table 1,
samples 1–3), three heterozygous (HE) (Table 1, samples 5–7), and three homozygous (HO) (Table 1, samples 9–11) PCFs. A: Equal protein amounts of whole
cell extracts were analyzed by Western blotting using antibodies directed against Cu/Zn-SOD, Mn-SOD, GPx, and GR. Bands corresponding to Cu/Zn-SOD (B),
Mn-SOD (C), GPx (D), and GR (E) were quantified using ImageJ software and normalized to -actin. Molecular size markers are indicated at the right. Values
are the mean  SD of three independent experiments. Statistical analysis was performed by one-way analysis of variance, followed by Newman–Keuls multiple
comparison test. *P  0.05; **P  0.01.
Table 2. Total SOD and Catalase Activities in Wild-Type (Table 1, samples 1–3), Heterozygous (Table 1, samples 5–7), and
Homozygous (Table 1, samples 9–11) PCFs
Enzymes WT HE HO
Total SOD activity 36.17  7.46 50.83  5.41* 57.58  5.91*
Catalase activity 0.04947  0.0018 0.01723  0.00025* 0.01833  0.0029*
Results were calculated in units of activity per mg of total protein. One unit of SOD activity was defined as the enzyme activity required to inhibit the
production of formazan by 50%. One U was the amount of catalase that decomposed 1 mmol/L H2O2/min. Values are the mean  SD of two or three
independent cultures with three replicates each. Statistical analysis was performed by one-way ANOVA, followed by Newman-Keuls multiple
comparison test.
*P  0.05, heterozygote (HE) or homozygote (HO) versus wild-type (WT) cultures.
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oxidative damage. Accordingly, we estimated oxidative
damage by quantifying levels of the lipid peroxidation
products, MDA and 4-HNE, and we quantified protein
oxidative damage using protein carbonyl formation as a
marker. The levels of protein carbonyl groups (Figure
5A), MDA (Figure 5B), and 4-HNE (Figure 5C) were sig-
nificantly elevated in GCD II PCFs compared with wild-
type PCFs. Next, to confirm oxidative damage in corneal
tissues of GCD II patients, we investigated the distribu-
tion of MDA using immunohistochemical staining. As
shown in Figure 5, D–G, MDA immunoreactivity was de-
tectable in the epithelial cells of corneal tissue from both
age-matched normal controls and GCD II patients. In
contrast, stronger immunoreactivity of MDA was ob-
served in the corneal stroma and epithelia of GCD II
patients (Figure 5, F and G), as compared with age-
matched normal corneal tissue (Figure 5, D and E). In
addition, immunostaining of corneal tissues showed a
positive reaction with TGFBIp specific antibody (KE-2) in
all examined samples (Figure 5, H–K). These results also
revealed that mutant TGFBIp is a major component of
corneal deposits (Figure 5, J and K). In corneal stroma,
typical fusiform deposits of different sizes showed in-
tense staining with the specific KE-2 antibody (Figures 5,
J and K). TGFBIp staining was also noticed within the
cytoplasm of epithelial cells.
Figure 3. Expression of catalase protein is reduced while CAT mRNA is
elevated in GCD II PCFs. A: Immunoblot analysis of catalase expression
among three wild-type (WT) (Table 1, samples 1–3), three heterozygous (HE)
(Table 1, samples 5–7), and three homozygous (HO) (Table 1, samples 9–11)
PCFs. B: Expression level of catalase is significantly reduced in heterozygotes
and homozygotes, as compared with wild-type PCFs. C and D: RT-PCR data
indicate that the level of CATmRNA was significantly higher in heterozygotes
and homozygotes as compared with wild-type PCFs. E–J: The subcellular
localization of catalase and TGFBIp in homozygous and wild-type PCFs.
Immunostaining for catalase was less intense in homozygous (H: Table 1,
sample 10) than wild-type (E: Table 1, sample 1) PCFs. Magnification60.
Molecular size markers are indicated at the right. Values are the mean  SD
of three independent experiments. Statistical analysis was performed by
one-way analysis of variance, followed by Newman–Keuls multiple compar-
ison test. **P 0.01, heterozygous or homozygous versus wild-type cultures.
Figure 4. Generation of ROS and H2O2 elevation in GCD II PCFs. Wild-type
(WT) (Table 1, samples 2–3), heterozygous (HE) (Table 1, samples 6–7), and
homozygous (HO) (Table 1, samples 9–10) PCFs were incubated with 2,
7-dichloro-fluorescein (DCF) and BES-H2O2 for 30 minutes and the levels of
ROS and H2O2 were determined as described in Materials and Methods.
Generation of ROS (A) and H2O2 (B) was significantly higher in heterozy-
gous and homozygous PCFs, as compared with wild-type PCFs. Values are
the mean  SD of at least three independent experiments. Statistical analysis
was performed by one-way analysis of variance, followed by Newman–Keuls
multiple comparison test. ***P  0.001 heterozygous or homozygous versus
wild-type cultures.
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Catalase is Down-Regulated in Wild-Type PCFs
Transfected with BIGH3 Gene
To investigate whether mutant BIGH3 (BIGH3-R124H) ex-
pression in wild-type cells induces heterozygous PCF-
like properties, we transfected wild-type PCFs with a
plasmid containing the BIGH3-R124H or the BIGH3 gene.
Surprisingly, catalase was significantly decreased in
PCFs transfected with BIGH3-R124H as well as BIGH3
(Figure 6, A and B). Furthermore, catalase expression
decreased more in PCFs transfected with BIGH3-R124H
than in PCFs transfected with BIGH3 (Figure 6, A and B).
In addition, because catalase and GPx are physiologi-
cally involved in the elimination of H2O2, to determine
whether these cells compensate for their ROS burdens
induced by decreased catalase, we assayed expression
of various antioxidant enzymes in cells transfected with
the BIGH3 and BIGH3-R124H genes. We found that lev-
els of Cu/Zn-SOD, Mn-SOD, GPx, and GR expression
showed an increase in cells transfected with BIGH3-
R124H or BIGH3 (Figure 6A). Furthermore, these levels
tended to be slightly increased in cells transfected with
BIGH3-R124H (Figure 6A). This result is the first evidence
that TGFBIp could regulate catalase expression. In-
creased antioxidant enzymes also revealed that cells
compensate for their increased ROS burdens by de-
Figure 5. Immunoblot analyses of carbonylated proteins, MDA, and 4-HNE in between GCD II and wild-type (WT) PCF, and immunohistochemical staining for
MDA and TGFBIp in corneal tissue. Levels of carbonylated proteins in PCF extracts were determined with an OxyBlot Protein Oxidation Detection Kit. Western
blotting for oxidatively modified proteins using anti-dinitrophenylhydrazone demonstrated a significant difference between wild-type controls and GCD II PCFs.
Densitometric evaluation of the Western blots showed significant differences in protein carbonyl (A), MDA (B), and 4-HNE (C) between wild-type and GCD II
PCFs (Table 1, samples 2–6, 11–12). Corneal tissues of a homozygote GCD II patient (F and G) show strong immunoreactivity to MDA (Table 1, samples 7 and
13). In a normal aged-matched cornea (D and E, Table 1, sample 4), MDA immunoreactivity was present in the cytoplasmic compartments of epithelial cells. The
corneal stroma also displayed diffused MDA immunoreactivity. In a GCD II cornea (F and G, Table 1, samples 13–14), strong MDA immunoreactivity was present
in the cytoplasmic compartments of most epithelial cells (EP) as well as the stromal matrix (ST). The immunohistochemical staining for TGFBIp is most prominent
in epithelial cells (asterisk). TGFBIp deposits (arrows) are shown on the stroma of corneal tissue (J and K): normal (H and I, Table 1 sample 1) and homozygote
cornea (J and K, Table 1, sample 13). Molecular size markers are indicated at the right. Values are the mean  SD of three independent experiments. Statistical
analysis was performed by one-way analysis of variance, followed by Newman–Keuls multiple comparison test. *P  0.05; **P  0.01, heterozygous (HE) or
homozygous (HO) versus wild-type cultures. Magnification  original 200.
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creased catalase. Next, because it has been reported
that catalase is targeted to the lysosomes for degradation
during autophagy,31,32 to assess whether the decrease in
catalase is involved in autophagic degradation, we
treated a normal human corneal fibroblast cell line29 with
an autophagy inducer, rapamycin. It has been well
known that increased LC3-II protein indicates generation
of autophagy. LC3-II protein increased in cells treated
with rapamycin in a dose-dependent manner (Figure 6C),
and catalase level dramatically decreased in cells
treated with rapamycin in a dose-dependent manner
(Figure 6C). In addition, to explore whether catalase is
targeted to the lysosomal compartment for degradation,
we monitored catalase localization by confocal micros-
copy in homozygous and wild-type PCFs. Catalase was
colocalized with the lysosomal marker protein LAMP-2 in
homozygous PCFs (Figure 6, G–I) but not in wild-type
PCFs (Figure 6, D–F). These results suggest that de-
creased catalase is involved in autophagic degradation.
CAT Gene Polymorphisms Are Not Involved in
Reduced Catalase Protein Levels in GCD II
PCFs
In many cases, polymorphisms of genes leading to a
reduction of protein and mRNA stability have been pos-
tulated to be a possible mechanism. The human catalase
gene consists of 13 exons and is located on chromosome
11p13.33 Several rare mutations/polymorphisms have
been reported in the catalase gene, most of them being
associated with acatalasemia. Therefore, to determine
whether the genetic basis is associated with reduced
catalase level, we investigated a mutation and polymor-
phism in structural gene and promoter of CAT gene from
the samples used in this study. However, we did not find
any polymorphism or mutation in CAT genes from normal
and GCD II patients (data not shown). These observa-
tions suggest that the reduction of catalase expression in
GCD II PCFs is not due to a marked mutant or polymor-
phism of CAT gene. However, larger sample sizes, intron,
and the 5- and 3-untranslated region of CAT gene need
further investigation. Primers and PCR conditions for spe-
cific amplification of CAT gene are provided in supple-
mentary Table S1 (see http://ajp.amjpathol.org).
Differential Expression of Cell Death- and
Survival-Related Proteins in GCD II PCFs
Because ROS-induced oxidative damages result in cell
death, we analyzed the expression levels of apoptosis-
related proteins. The expression of Bcl-2 (Figure 7, A and
B) and Bcl-xL (Figure 7, A and C) was significantly lower
in heterozygous and homozygous PCFs, as compared
with wild-type PCFs, while the expression of Bax (Figure
7, A and D) and Bok (Figure 7, A and E) proteins was
significantly higher in GCD II PCFs.
Figure 6. Expression levels of catalase and
other antioxidants enzymes in normal PCFs
transfected with BIGH3 genes. A: Wild-type
(WT) PCFs (Table 1, samples 3 and 4) were
either transfected with wild-type BIGH3, mutant
BIGH3 (R124H), or nontransfected (Mock).
Cells were harvested 48 hours after transfection.
Proteins (25 g) were analyzed by Western blot-
ting. Actin was used as a loading control. Cata-
lase level is down-regulated in wild-type PCFs
transfected with BIGH3 or BIGH3–R124H gene.
B: The amount of catalase is decreased signifi-
cantly in BIGH3–R124H transfectants compared
with BIGH3 transfectants. Values are the
mean  SD of three independent experiments.
C: Catalase level is decreased in the normal
human corneal fibroblast cell line treated with
autophagy inducer, rapamycin. After exposure
to rapamycin for 12 hours, cell lysates were
subjected to Western blot analysis using an an-
tibody against LC3 and catalase. An anti--actin
antibody was used to confirm equal loading of
proteins. D–I: Catalase is present inside the ly-
sosomal compartment in GCD II PCFs. PCFs
cells were fixed, permeabilized, blocked, and
stained with catalase-specific antibody (D and
G: green), or LAMP-2 (E and H: red) antibody.
The secondary antibodies were conjugated with
either fluorescein isothiocyanate or Alexa 594.
Cells were viewed with a confocal microscope.
Green fluorescence for catalase stain, red fluo-
rescence for lysosomal stain (LAMP-2), and the
merged images (MERGE) are shown. Colocal-
ization is indicated by yellow. Magnification 
original 60.
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GCD II PCFs Are More Sensitive to H2O2-
Induced Cell Death Than Wild-Type PCFs
To further investigate the role of oxidative stress in GCD
II, we analyzed the effects elicited by incubating GCD II
and wild-type PCFs for 6 hours in the presence of 0, 100,
or 200 mol/L H2O2 (Figure 8). First, we performed An-
nexin-V/PI-FACS analyses to determine whether the ob-
served cell death occurred via the process of apoptosis
(Figure 8A). Significantly more H2O2-treated cells dis-
played early morphological events of apoptosis (wild-
type: 5.4%; homozygous: 15.2%) in 100 mol/L treatment
and apoptosis (wild-type: 8.3%; homozygous: 17.0%) in
200 mol/L treatment than untreated cells (wild-type:
2.1%; homozygous: 4.6%) (Figure 8A). Second, we de-
termined cell viability using MTS reduction. The viability
of primary cultured heterozygous and homozygous PCFs
declined significantly within 6 hours in the presence of
various H2O2 concentrations compared with wild-type
(Figure 8B). After exposure to 100, 150, 200, and 250
mol/L H2O2 for 6 hours, cell viability in wild-type PCFs
decreased by about 85.38, 79.75, 71.58, and 50.13%,
respectively (P  0.05). In contrast, cell viability in het-
erozygous PCFs decreased by about 78.96, 64.30,
50.93, and 37.15%, respectively (P  0.05). The cell
viability of homozygous PCFs was the most susceptible
to H2O2, with cell viability reductions of about 63.51,
42.35, 24.66, and 12.19%, respectively (P  0.05).
Discussion
Our results provide the first evidence for the involvement
of oxidative stress in the pathogenesis of GCD II. This
novel role is supported by the following observations in
GCD II PCFs: (1) increased Cu/Zn-SOD, Mn-SOD, GPx,
and GR expression, and decreased catalase expression;
(2) increased intracellular ROS and H2O2 generation; (3)
increased 4-HNE, MDA, and protein carbonyl groups
content, as well greater MDA immunoreactivity in GCD II
corneal tissues; (4) decreased catalase in wild-type PCFs
transfected transiently with BIGH3 gene; (5) decreased
Bcl-2 and Bcl-xL expression, and increased Bax and Box
expression; and (6) increased susceptibility to oxidative
stress-induced cell death.
Aging and age-related or protein aggregation-related
diseases appear to have a common type of oxidative
Figure 7. Differential expression of cell death- and survival-related proteins.
Levels of Bcl-2, Bcl-xL, Bax, and Bok were detected by immunoblotting in
the cell lysates of wild-type and GCD II PCFs. A: Equal amounts (50 g) of
protein from each sample were immunoblotted with anti-Bcl-2, anti-Bcl-xL
anti-Bax, anti-Bok, and anti--actin antibodies. A statistically significant de-
crease in Bcl-2 (B) and Bcl-xL (C) and increase in Bax (D) and Bok (E) was
detected in GCD II PCFs (Table 1, samples 6–11), as compared with wild-
type PCFs (Table 1, samples 2–4). Values are the mean  SD of three
independent experiments. Statistical analysis was performed by one-way
analysis of variance, followed by Newman–Keuls multiple comparison test. *
P  0.05; **P  0.01; ***P  0.001, heterozygous (HE) or homozygous (HO)
versus wild-type cultures. Molecular masses are indicated in kDa.
Figure 8. GCD II PCFs are most susceptible to H2O2-induced cell death. A: Assay of apoptotic cell death by FACS analysis. PI-stained wild-type (WT) (Table 1,
sample 1) and homozygous (HO) (Table 1, sample 10) PCFs were FACS-sorted after exposure to 100 mol/L and 200 mol/L H2O2. A statistically significant
increase in apoptotic cells was detected in GCD II PCFs, as compared with control cells. B: Cell viability of wild-type (Table 1, samples 1 and 2), heterozygous
(HE) (Table 1, samples 5 and 6), and homozygous (Table 1, samples 9–10) PCFs was determined by MTS assay after 6 hours stimulation with various concentration
of H2O2. Cell viability was calculated by the equation: MTS OD value of sample/MTS OD value of control (cells treated with PBS). Values are the mean  SD
of at least three independent experiments.
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damage.34,35 Because the cornea absorbs approxi-
mately 80% of UV B light, it has the greatest potential for
elevated ROS generation and/or oxidative stress. GCD II
is an autosomal dominant genetic disorder characterized
by age-dependent progressive accumulation of TGFBIp
deposits in the epithelia and stroma of the cor-
nea.23,24,36,37 TGFBIp deposits are also involved in the
degenerated corneal fibroblasts that are observed in the
corneal stroma of GCD.38 Despite the numerous antioxi-
dant systems in mammalian cells, ROS generation can
increase under normal aging and pathophysiological
conditions through an altered oxidant-antioxidant status.
Several studies have also demonstrated that the aggre-
gated proteins associated with diseases can elevate the
generation of ROS, and that the increased ROS may
constitute a fundamental mechanism in oxidative dam-
age and cell death. The regulatory responses of antioxi-
dant enzyme genes to oxidative stress have been de-
scribed.39 For example, the expression of both Mn-SOD
and GPx is induced by ROS, with little change in Cu/Zn-
SOD or catalase. Shull et al also demonstrated the great-
est induction of catalase expression in response to H2O2
and smaller increases in GPx and Mn-SOD expression.40
These data suggest that the increased levels of both
Cu/Zn- and Mn-SOD in GCD II PCFs are dynamic re-
sponses to ROS and/or oxidative stress. Similarly, the
increase in expression of both GPx and GR may relate to
a defensive response to elevated intracellular H2O2.
Catalase is a major enzyme involved in the detoxification
of H2O2 from cells, and increased levels of catalase by
transcriptional activation can be found in H2O2-stressed
various cell lines.41–43 However, the regulation of cata-
lase expression under oxidative stress is not predict-
able. For example, activity and protein and/or mRNA of
catalase are decreased,44–51 increased,52–54 or un-
changed55 during oxidative stress. Furthermore, catalase
increased at both the mRNA and protein levels with a
conformable increase in catalase enzyme activity, but no
differences exist in expression of Mn-SOD, CuZnSOD,
and GPx.56 Several studies have also described adaptive
regulation of activities of catalase exposure to H2O2. In
fact, levels of mRNA and protein of catalase are induced
by a low concentration of H2O2 in human lens epithelial
cells.57 In addition, catalase activities, protein levels, and
mRNA levels increased markedly by enhanced mRNA
stability of catalase through multiple exposures to a low
dose of H2O2 in fibroblasts.
58 On the other hand, it has
been shown that ceramide treatments induce oxidative
damage through proteolytic cleavage of catalase by ac-
tivated caspase-3. Activated caspase-3 decreased cata-
lase protein levels because of its proteolysis, not be-
cause of inhibition of mRNA levels.59 Finally, cytokines
and nitric oxide inhibit enzyme activity of catalase but not
its protein or mRNA expression.60 Although regulation of
catalase is complex, in this study, increased mRNA ex-
pression of catalase is most easily explained as a re-
sponse to elevated H2O2, because increased H2O2 gen-
eration was also observed in GCD II PCFs. Furthermore,
decreased catalase and increased SODs activities can
accelerate H2O2 generation by increasing the conversion
of O2
 into H2O2, which causes cellular oxidative dam-
age such as lipid peroxidation and/or cell death.61 In-
creased MDA (Figure 5B), 4-HNE (Figure 5C), and pro-
tein carbonyl group (Figure 5A) levels has been found in
GCD II PCFs. These results suggest that decreased cata-
lase and increased SOD expression may be responsible
for the excessive oxidative damage in GCD II PCFs.
Therefore, reduced catalase activity reveals that corneas
of patients with GCD II may suffer from elevated H2O2
levels. Furthermore, corneal tissue is chronically exposed
to solar UV radiation and high levels of oxygen,2 and is
known to be particularly susceptible to oxidative stress.3
Taken together, we propose that decreased catalase in
GCDII PCFs could make the cornea more susceptible to
oxidative stress in corneas of patients with GCD II.
Numerous studies have demonstrated a strong corre-
lation between oxidative stress and apoptosis in different
cell types.61,62 Thus, oxidative stress leads to apoptosis
when antioxidant capacity is insufficient.62 Therefore,
these findings provide a possible link between apoptosis
and oxidative stress in the degeneration of corneal fibro-
blasts in GCD II. Previously, the relationship between
corneal fibroblasts apoptosis and antioxidant enzymes
levels has been also demonstrated in corneal surgeries
such as photorefractive keratectomy and laser in situ
keratomileusis.63–66 Excimer laser stromal photoablation
also induces a decrease in corneal GPx activity,65 and
the apoptosis of corneal fibroblast is induced by de-
creased GPx activity after corneal epithelial scraping.66
Furthermore, the low level of H2O2 caused by the up-
regulation of catalase protects against apoptosis.67
Taken together, we suggest that the heightened suscep-
tibility of GCD II PCFs to H2O2-induced cell death may be
caused by decreased catalase expression. We also
showed that a decline in the anti-apoptotic protein Bcl-2
was involved in the apoptotic cell death of GCD II PCFs.
Lower levels of Bcl-2 can disturb its ROS scavenging
function,68 and overexpression of catalase leads to an
increase in Bcl-2 expression.69 By detoxifying ROS, cata-
lase reverses the reduction in Bcl-2 expression caused
by oxidative stress and prevents apoptosis. ROS and
Bcl-2 levels have a reciprocal relationship,70 where an
increase in ROS correlates with a decrease in Bcl-2 levels
and vice versa.71,72 This finding suggests that increased
generation of ROS may lead to a decline in Bcl-2 levels in
GCD II PCFs.
There are discrepancies between the mRNA and pro-
tein level of catalase in GCD II PCFs. To explain these
results, we here propose that the decreased catalase
protein level may be due to proteolytic degradation rather
than decreased translational activation. Autophagy plays
a known role in the degradation of peroxisomes, which
are subcellular organelles with a single membrane that
contains catalase mainly as a matrix enzyme.73,74 Li Yu et
al demonstrated that autophagy can lead to the degra-
dation of peroxisomal catalase, and the resulting accu-
mulation of ROS in the cell leads to cell death.31 More
recently, we also observed significantly greater autoph-
agy using Western blots for the autophagy marker LC3 in
GCD II PCFs, as compared with wild-type PCFs (unpub-
lished data). Furthermore, catalase-positive compart-
ments were frequently colocalized with LAMP-2 in ho-
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mozygous PCFs (Figure 6I), but not wild-type PCFs
(Figure 6F). These data suggest that catalase is de-
graded by a lysosomal degradation pathway via autoph-
agic processing. Therefore, we speculate that peroxiso-
mal degradation by autophagy may be involved in the
catalase degradation machinery in GCD II PCFs. In ad-
dition, several investigations have shown that catalase is
regulated by ubiquitination and proteosomal degrada-
tion.75 Recent study has revealed that there is specific
autophagic degradation of polyubiquitinated protein ag-
gregates as a clearance mechanism. This study also
showed that ubiquitination of both protein and cellular
compartments containing peroxisomes are efficiently tar-
geted to autophagosomes, and then degraded in lyso-
somes. Although we did not detect ubiquitinated catalase
in GCD II PCFs, based on these reports, we propose that
the ubiquitination of catalase involved in the selective
lysosomal targeting of catalase. Finally, because poly-
morphisms and mutation of genes leading to a reduction
of protein and mRNA stability have been postulated to be
a possible mechanism, to examine whether mutations
and polymorphisms of the CAT gene are associated with
decreased levels of catalase, we analyzed sequences of
13 exons in the CAT gene and its promoter from the blood
of patients and controls used in this study (see supple-
mental Table S1 at http://ajp.amjpathol.org). These data
suggest that the reduction of catalase expression in GCD
II PCFs is not due to a marked mutant or polymorphism of
the CAT gene. Taken together, although these results
reveal that the regulation of catalase has more complex
patterns, we consider the possibility that TGFBIp is in-
volved in the regulation of catalase protein.
It is well accepted that ROS can react rapidly with
almost all biological substances and induce the peroxi-
dation of lipids and proteins. ROS attacks on macromol-
ecules are another important cause of protein damage,
misfolding, and aggregation within cells.76,77 Notably,
protein aggregation is facilitated by partial unfolding dur-
ing oxidative stress. Therefore, aggregation and accumu-
lation of oxidatively damaged proteins occurs in cells or
tissues.78,79 Oxidative stress can also directly injure cor-
neal tissues by cleaving corneal stromal macromole-
cules, such as proteoglycans and collagen.80,81 These
studies reveal that corneal tissue damage induced by
oxidative stress may be involved in the developmental
processing of TGFBIp deposits, because TGFBIp most
easily interacts with type I collagen and fibronectin,82
which can be easily damaged by oxidative stress.76
Moreover, abnormal collagen and proteoglycan deposits
appear in the anterior stroma in GCD.83 Therefore, we
propose that TGFBIp deposits in corneal tissues may be
involved in specific associations between oxidatively
modified TGFBIp and extracellular matrix (ECM) compo-
nents. TGFBIp is ECM protein that has four internal repeat
domains homologous to the Drosophila protein fasci-
clin-1.84 The mutation (R124H) in TGFBIp is predicted to
alter either protein solubility or stability,85 and likely af-
fects protein–protein interactions in ECM.85 Extracellular-
SOD also catalyzes the breakdown of O2
 to H2O2 in
ECM. This enzyme has high affinity with sulfated glycos-
aminoglycans and mainly exists anchored to proteogly-
cans in ECM.86,87 Because it has been demonstrated that
TGFBIp mediates cell adhesion by interacting with vari-
ous ECM components, such as proteoglycan, collagens,
fibronectin, and several integrins,82,88 we consider that
the mutation of TGFBIp may lead to changes in proteo-
glycan and collagen structure and subsequence it may
accelerate the oxidative damage by lack of binding sites
of extracellular SOD in the ECM.
The functional significance of the TGFBIp in the cornea
is still unclear. Here we suggest that TGFBIp could reg-
ulate metabolism of catalase. Although, no interactions
between TGFBIp and catalase, as revealed by co-immu-
noprecipitation assays, have been found (data not
shown), this is supported by significantly decreased
catalase in PCFs transfected with mutant BIGH3 or wild-
type BIGH3 and by colocalization between TGFBIp and
catalase in cytosolic compartment of PCFs.
In conclusion, the oxidative damage induced by de-
creased catalase activity may play a pivotal role in the
pathogenesis of GCD II, potentially providing a therapeu-
tic intervention strategy that involves antioxidant agents.
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